Nemes Rush Group’s Acadia Healthcare ACHC Stock Holding History

Nemes Rush Group’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$71	–	944
2025 Q4	$71	Buy	+5	New	+$95	﹤0.01%	983

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nemes Rush Group's ACHC Position: Q1 2026 in Review

Nemes Rush Group sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 5 shares — an estimated $71 sold.

Nemes Rush Group first reported a position in ACHC in Q4 2025 and held it in 1 quarter. The position peaked at $71 in Q4 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

Nemes Rush Group reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
Nemes Rush Group sold 5 Acadia Healthcare shares in Q1 2026, an estimated $71.
Nemes Rush Group first reported a position in Acadia Healthcare in Q4 2025 and held it in 1 quarter.
Nemes Rush Group's Acadia Healthcare position peaked at $71 in Q4 2025.
295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.